Диссертация (1139652), страница 29
Текст из файла (страница 29)
Impaired fetal adrenal function in intrahepatic cholestasis of pregnancy / C.Wang [et al.] // Med Sci Monit. – 2011. – Vol.17, №5.- P. 265-271.137. Improved prognosis of patients with primary biliary cirrhosis that have abiochemical response to ursodeoxycholic acid / E.M. Kuiper [et al.]Gastroenterology.–2009.-№136.–P.1281–1287.//doi:10.1053/j.gastro.2009. 01.003.138. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitisin a United States community / K. Bambha [et al.] // Gastroenterology.
- 2003.- №125 - P.1364 –1369.139. Incidence, natural history, and risk factors for biliary sludge and stonesduring pregnancy / C.W. Ko [et al.] // Hepatology. – 2005. -№ 41. - 359-365.140. Increased prevalence of clinical gallbladder disease in subjects with noninsulin-dependent diabetes mellitus / S.M.Haffner [et al.]//Am. J.Epidemiol. – 1990. - №132. – P.327-335.141. Insulin resistance and incident gallbladder disease in pregnancy / C.W.
Ko[et al.] // Clin Gastroenterol Hepatol. - 2008. - №6. – P.76-81.142. Insulin resistance, dyslipidemia, and metabolic syndrome in women withpolycystic ovary syndrome / A. El-Mazny [et al.] // Int J Gynaecol Obstet. –2010. - №109. P. 239-241.192143. Interventions for treating cholestasis in pregnancy / V. Gurung [et al.] //Cochrane Database Syst. Rev. – 2013. - №6:CD000493.23794285.144. Intrahepatic cholestasis of pregnancy (ICP): case report and review of theliterature / V. Keitel [et al.] // Z.Gastroenterol. – 2016. - №54.
– P.13271333.145. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: apopulation-based cohort study / H.U. Marschall [et al.] // Hepatology. – 2013.– Vol. 58, №4. – P.1385-1391.146. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliarydiseases: a population-based study / A. Ropponen [et al.] //Hepatology. –2006. – Vol.43, №4. –P. 723-728.147. Intrahepatic cholestasis of pregnancy levels of sulfated progesteronemetabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype /S.
Abu-Hayyeh, G. Papacleovoulou, A. Lövgren-Sandblom [et al.] //Hepatology. – 2013 – Vol.57, №2. – P. 716-726.148. Intrahepatic cholestasis of pregnancy: a French prospective study. / Y. Bacq[et al.] // Hepatology. – 1997. - №26. – P. 358–364.149. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis andmanagement / F.
Lammert [et al.] // J Hepatol. -2000. –Vol.33, №6. -10121021.150. Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations /A. Floreani [et al.] // Aliment Pharmacol Ther. – 2006. – Vol. 23, №11. 1649-1653.151. IVF/ICSI treatment and the risk of spontaneous preterm birth in singletonpregnancies: a meta-analysis of cohort studies / P. Cavoretto [et al.]// Ultrasound Obstet Gynecol. – 2017. Nov 7. doi: 10.1002/uog.18930.152. Jauniaux E. The role of oxidative stress in placental-related diseases ofpregnancy / E.
Jauniaux, J. Burton // J Gynecol Obstet Biol Reprod (Paris). –1932016. – Vol. 45, №8. – P.775-785. doi: 10.1016/j.jgyn.2016.02.012. Epub2016 Jul 7.153. Jones E.A. The pruritus of cholestasis: from bile acids to opiate agonists /E.A. Jones, N.V. Bergasa // Hepatology. – 1990. – Vol.11, №884.– P.887. doi:10.1002/hep.1840110526.154. Kiaii B. The basis for progesterone impairment of gallbladder contractilityin male guinea pigs in vitro / B.Kiaii, Q.W.Xu, E.A.Shaffer // J Surg Res.
–1998. – Vol.79, №2. – P. 97-102.155. Kline L.W. 17β-Estradiol relaxes cholecystokinin- and KCl-induced tensionin male guinea pig gallbladder strips / L.W.Kline, E. Karpinski Steroids. –2011. – Vol.76, №6. – P.553-557.156. Kline L.W. Progesterone inhibits gallbladder motility through multiplesignaling pathways / L.W. Kline, E. Karpinski // Steroids. –Vol. 70, № 9. 2005. -P. 673–679.157.
Ko C.W. Biliary sludge / C.W. Ko, J.H. Sekijima, S.P.Lee // Ann InternMed. – 1999. - №130. –P. 301-311.158. Ko C.W. Risk factors for gallstone-related hospitalization during pregnancyand the postpartum // Am J Gastroenterol. – 2006. - №101. – P. 2263-2268.159. Kocak I. Recurrent spontaneous abortion and selenium deficiency / I.Kocak,E.Aksoy, C.Ustun // Int J Gynaecol Obstet. – 1999. - №65. – P.
79-80.160. Kondrackiene J. Efficacy and safety of ursodeoxycholic acid versuscholestyramine in intrahepatic cholestasis of pregnancy / J. Kondrackiene,U.Beuers, L.Kupcinskas // Gastroenterology. – 2005. - №129. – P. 894–901.161. Kuhl C. Etiology and pathogenesis of gestational diabetes // Diabetes Care.-1998. – Vol.21, №2. – P.19 –26.162. Laatikainen T. Maternal serum bile acid levels and fetal distress incholestasis of pregnancy / T. Laatikainen, A.Tulenheimo // Int J GynaecolObstet. – 1984.
- № 22. – P. 91–94.194163. Lanzafame R.J. Disease of the gallbladder and pancreas in pregnancy //Surgery. – 1995. - №118. – P.627-631.164. Laparoscopic cholecystectomy and interventional endoscopy for galls- tonecomplications during pregnancy / P. Sungler [et al.] // Surg Endosc. – 2000. №14. - P. 267-271.165. Laparoscopic cholecystectomy in pregnancy / J.W.
Gouldman [et al.] //Am. Surg. – 1998. - № 64. – P.93-97. 166. Lartigau-Roussin C. Macro-AST and myeloma: an incidental association? /C. Lartigau-Roussin, M.H.Paclet, H. // Audin Rev. Med. Interne. – 2016.- (S0248-8663)(16)(30405-2).167. Lee M. Isolated aspartate aminotransferase elevation: Think macro-AST /M.Lee, P.Vajro, E.B. Keeffe // Dig. dis. sci. – 2011. - №56. – P.311–313.168. Lee N.M.
Nausea and vomiting of pregnancy / N.M.Lee,S.Saha// Gastroenterol Clin North Am. – 2011. - №40. – P.309–334.169. Lindseth G. Risk factors for cholelithiasis in pregnancy / G. Lindseth, M.Y.Bird-Baker // Res Nurs Health. – 2004. - №27. - P. 382-391.170. Linkage between a new splicing site mutation in the MDR3 alias ABCB4gene and intrahepatic cholestasis of pregnancy / G. Schneider [et al.] //Hepatology. – 2007.
– Vol.45, №1. – P.150-158.171. Longitudinal changes in glucose metabolism during pregnancy in obesewomen with normal glucose tolerance and gestational diabetes mellitus / P.M.Catalano [et al.] // Am J Obstet Gynecol. – 1999. - №180. – P.903–916.172. Low serum selenium concentration and glutathione peroxidase activity inintrahepatic cholestasis of pregnancy / A.Kauppila [et al.] // Br Med J (ClinRes Ed). – 1987. - №294. – P.150-152.173.
Macro-AST in an asymptomatic young patient / H. Chtioui [et al.] // Fr.annals of hepatology. – 2010. – Vol. 9, №1. – P.93–95.174. Maier K.P. Hepatitis – Hepatitisfolgen. / Auflage. Bern: Hans Huber Verlag.- 2010.195175. Malinova M. Selenium and glutathione peroxidase in patients withpreeclampsia / M.Malinova, V.Paskaleva // Akush Ginekol (Sofiia). -2013. –Vol. 52, №5. – P.3-7.176. Management of primary sclerosing cholangitis / Lee Y.M. [et al.] // Am JGastroenterol. – 2002. - №97. – P. 528–534.177. Marchioni Beery R.M. Primary Biliary Cirrhosis and Primary SclerosingCholangitis: a Review Featuring a Women's Health Perspective / R.M.Marchioni Beery, H.Haleh Vaziri, F.Forouhar // J Clin Transl Hepatol. - 2014.– Vol.2, №4. – P.266–284.178. May G.R. Efficacy of bile acid therapy for gallstone dissolution: a metaanalysis of randomized trials / G.R.
May, L.R.Sutherland, E.A. Shaffer //Aliment. Pharmacol Ther. - 1993. - Vol. 7, №2. - P. 139–148.179. Medical versus surgical management of biliary tract disease in pregnancy /E.J. Lu [et al.] // Am J Surg. – 2004. – Vol.188. – P.755-759.180. Million Women Study Gallbladder disease and use of transdermal versusoral hormone replacement therapy in postmenopausal women: prospectivecohort study / Liu B. [et al.] // BMJ. – 2008. - Jul 10;337:a386.181. Momah N.
Primary biliary cirrhosis in adults / N.Momah, K.D. Lindor //Expert Rev Gastroenterol Hepatol. – 2014. - №8 – P. 427–433. doi:10.1586/17474124.2014. 888950.182. Moriyama T. Laboratory and clinical features of abnormal macroenzymesfound in human sera / T.Moriyama, S.Tamura, K.Nakano // Biochim. Biophys.Acta. – 2015. - №1854. – P.658–667.183. Nausea and vomiting of pregnancy: prevalence, severity and relation topsychosocial health / Kramer J.
[et al.] // MCN Am J Matern Child Nurs.- 2013 P.21–27.184. New insights into the molecular mechanisms underlying effects of estrogenon cholesterol gallstone formation / H. Wang [et al.] // Biochim Biophys Acta.– 2009. – Vol.1791, №11. - P.1037–1047.196185. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR,PXR and beyond.
/ U. Beuers [et al.] // Hepatol. – 2015. - №62(Suppl). – P.25-37.186. Niv Y. Gender medicine in gastroenterology // Isr Med Assoc J. – 2011. –Vol.13, №4. – P.244-246.187. Non-gynecologic laparoscopy in second and third trimester pregnancy:obstetric implications / J.P. Geisler // JSLS. – 1998. - №2. - P.235-238.188. Oral contraceptives and other risk factors for gallbladder disease / B.L.Strom [et al.] // Clin Pharmacol Ther. – 1986. - №39. – P.335-341.189. Oral contraceptives and the risk of gallbladder disease: a comparative safetystudy / M.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
